_PRIVATE_LIMITED.webp)
Prim Drugs & Pharmaceuticals (India) Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
as on 17-06-2024
- Paid Up Capital ₹ 8.00 M
as on 17-06-2024
- Company Age 15 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.60 Cr
as on 17-06-2024
- Satisfied Charges ₹ 5.00 M
as on 17-06-2024
- Revenue 174.73%
(FY 2023)
- Profit -365.81%
(FY 2023)
- Ebitda -105.55%
(FY 2023)
- Net Worth -12.05%
(FY 2023)
- Total Assets 20.94%
(FY 2023)
About Prim Drugs & Pharmaceuticals (India)
The Corporate was formerly known as Sujam Formulations Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 8.00 M.
The company currently has active open charges totaling ₹4.60 Cr. The company has closed loans amounting to ₹5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Srinivasan Sellappan and Subramanian Kavitha serve as directors at the Company.
- CIN/LLPIN
U51909TN2009PTC073934
- Company No.
073934
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Dec 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Porur, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Prim Drugs & Pharmaceuticals (India) Private Limited offer?
Prim Drugs & Pharmaceuticals (India) Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Anti Infective Agent.
Who are the key members and board of directors at Prim Drugs & Pharmaceuticals (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivasan Sellappan  | Director | 15-Dec-2009 | Current |
| Subramanian Kavitha | Director | 15-Dec-2009 | Current |
Financial Performance of Prim Drugs & Pharmaceuticals (India).
Prim Drugs & Pharmaceuticals (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 174.73% increase. The company also saw a substantial fall in profitability, with a 365.81% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prim Drugs & Pharmaceuticals (India)?
In 2023, Prim Drugs & Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vals Lifescience Private LimitedActive 9 monthsSrinivasan Sellappan and Subramanian Kavitha are mutual person
Charges (Loans)
₹45.98 M
₹5.00 M
Charges Breakdown by Lending Institutions
- Others : 4.60 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Dec 2023 | Others | ₹2.50 Cr | Open |
| 10 Nov 2022 | Others | ₹5.00 M | Open |
| 17 Dec 2020 | Others | ₹1.00 Cr | Open |
| 15 Mar 2019 | Others | ₹5.98 M | Open |
| 24 Jul 2020 | City Union Bank Limited | ₹5.00 M | Satisfied |
How Many Employees Work at Prim Drugs & Pharmaceuticals (India)?
Prim Drugs & Pharmaceuticals (India) has a workforce of 30 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prim Drugs & Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prim Drugs & Pharmaceuticals (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.